Please try another search
Goldman Sachs has downgraded its rating for Dr Lal PathLabs to 'sell', leading to a 3% fall in the company's shares to Rs 2,431 ($1 = Rs 83.26). This marks the third consecutive day of losses for the...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review